[Da Yin Xi Sheng] Frontier leader, Professor Chen Minshan talks about the new progress of systemic treatment of liver cancer

Posted on by Moderator

Generous without corners, late bloomers, great sounds and voices, elephants are invisible. The “Big Voice” column created by Lilly Oncology talks about the new concept of liver cancer diagnosis and treatment from the perspective of big coffee. This program specially invites Professor Chen Minshan, Director of Liver Surgery, Sun Yat-sen University Cancer Prevention Center, to share the latest progress in liver cancer treatment and breakthroughs in first-line immunotherapy .

Expert Profile

Professor Chen Minshan

    < li>

    Director of Liver Surgery, Sun Yat-sen University Cancer Center

  • Director of Sun Yat-sen University Liver Cancer Research Institute p>

  • Chairman of the Liver Cancer Professional Committee of the Chinese Anti-Cancer Association

  • Liver Cancer Professional of the Chinese Medical Doctor Association Vice Chairman of the Committee

  • Vice Chairman of the Chinese Society of Clinical Oncology (CSCO) Liver Cancer Working Committee

  • Former Chairman of the Liver Cancer Branch of Guangdong Medical Association

  • Honorary Chairman of the Liver Cancer Professional Committee of Guangdong Anti-Cancer Association

  • Member of the Liver Surgery Group, Chinese Medical Association Surgery Branch

  • Member of the Liver Cancer Group of the Chinese Society of Hepatology

  • Member of the Hepatoma Group of the Chinese Society of Oncology p>

  • 2013-2016 Top 100 Chinese Famous Doctors

  • The first “Zhongshan” in 2014 University Doctor”< /p>

  • 2015, 2018 Lingnan Famous Doctors

  • The first “Guangdong Good Doctor” in 2017 Doctor” Award

  • 2018 Honor Doctor Specialist Elite Award for Liver Disease

  • Focusing on clinical multidisciplinary treatment of liver cancer, with thousands of clinical experience in liver resection, radiofrequency ablation of liver cancer and interventional therapy for liver cancer (TACE). The academic development direction is the research on multidisciplinary treatment of liver cancer and radiofrequency ablation.

Copyright belongs to the original author

For more exciting content, please click Read the original textView details

in the lower left corner